- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 170 results
Webinar
Januar 28, 2025
Overpayments, Internal Investigations and FCA Updates: What Providers Need to Know for Continued Compliance in 2025
Webinar
Januar 28, 2025
Food for Thought: What the Food & Beverage Industry Can Expect in 2025
Webinar
Januar 22, 2025
Year in Review for Drug and Device Advertising and Promotion
Webinar
Januar 16, 2025
Steps Before Marketing Authorization (MA)
Webinar
Dezember 18, 2024
Changed Landscape? How 2024 Elections Will Impact Healthcare M&A
Webinar
Dezember 4, 2024
Fundamentals of EU Pharmaceutical Law
Webinar
November 28, 2024
Virtual Talk im Turm: Health Claims in Advertising Botanicals (ECJ Case C-386/23)
Webinar
November 27, 2024
Virtual Talk im Turm: EU Regulation on “Green Claims” – How to Ensure Compliance
Webinar
November 14, 2024
A Provider’s Guide to Information Blocking: Where We Are Now and What to Expect in 2025
Webinar
Oktober 24, 2024
Real-World Data for Clinical Trials: Brand New FDA Expectations for Use of Real-World Evidence for Regulatory Decision-Making
Webinar
September 19, 2024
Hot Topics in Behavioral Healthcare
Webinar
September 18, 2024
Addressing Misinformation: Insights on Social Media and Influencer Marketing